Trelegy Approval Boosts GSK's US Respiratory Business But Pressure Remains

 
• By Eleanor Malone
Conceptual image of green tree shaped like human lungs
Trelegy is the lone COPD triple therapy in the US...for now

More from New Products

More from Scrip